Authors
Arjan Diepstra, Gustaaf W van Imhoff, Henrike E Karim-Kos, Anke van den Berg, Gerard J te Meerman, Marijke Niens, Ilja M Nolte, Esther Bastiaannet, Michael Schaapveld, Edo Vellenga, Sibrand Poppema
Publication date
2007/7/20
Journal
Journal of clinical oncology
Volume
25
Issue
21
Pages
3101-3108
Publisher
American Society of Clinical Oncology
Description
Purpose
The neoplastic Hodgkin Reed-Sternberg (HRS) cells in classical Hodgkin's lymphoma (cHL) are derived from B cells. The frequency of HLA class II downregulation and its effect on prognosis are unknown.
Patients and Methods
Immunohistochemistry results for HLA class II were evaluated in 292 primary cHL patients in a population-based approach. Patients were diagnosed between 1989 and 2000 in the northern part of the Netherlands. Median age at diagnosis was 38 years (range, 8 to 88 years); 63% had Ann Arbor stage I or II, 24% stage III, and 13% stage IV disease. Median follow-up was 7.1 years. For 168 patients, HLA genotype data were available.
Results
Lack of HLA class II cell-surface expression on HRS cells was observed in 41.4% and was more common in patients with extranodal disease, patients with Epstein-Barr virus–negative disease, and …
Total citations
200620072008200920102011201220132014201520162017201820192020202120222023202412351271110913101213101515824